PP
AZN icon

Pacifica Partners’s AstraZeneca AZN Stock Holding History

Pacifica Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-55
Closed -$9.2K – 462
2025
Q3 		$9.2K Buy
55
+27
+96% +$4.09K ﹤0.01% 344
2025
Q2 		$3.84K Hold
28
– – ﹤0.01% 411
2025
Q1 		$4.07K Hold
28
– – ﹤0.01% 393
2024
Q4 		$3.62K Hold
28
– – ﹤0.01% 399
2024
Q3 		$4.29K Hold
28
– – ﹤0.01% 411
2024
Q2 		$4.22K Hold
28
– – ﹤0.01% 423
2024
Q1 		$3.62K Buy
+28
New +$3.71K ﹤0.01% 432
2020
Q2 		– Sell
-11
Closed -$1K – 374
2020
Q1 		$1K Buy
11
+1
+10% +$94 ﹤0.01% 347
2019
Q4 		$1K Buy
+10
New +$941 ﹤0.01% 349

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pacifica Partners's AZN Position: Q4 2025 in Review

Pacifica Partners sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 55 shares — an estimated $9.2K sold.

Pacifica Partners first reported a position in AZN in Q4 2019 and held it in 9 quarters. The position peaked at $9.2K in Q3 2025. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • Pacifica Partners reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
  • Pacifica Partners sold 55 AstraZeneca shares in Q4 2025, an estimated $9.2K.
  • Pacifica Partners first reported a position in AstraZeneca in Q4 2019 and held it in 9 quarters.
  • Pacifica Partners's AstraZeneca position peaked at $9.2K in Q3 2025.
  • 1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Pacifica Partners's 13F filing for Q4 2025, filed 9 Jan 2026.